Ciprofloxacin resistance among nosocomial Pseudomonas aeruginosa and Staphylococcus aureus in the United States

作者: Victor G Coronado , Jonathan R Edwards , David H Culver , Robert P Gaynes , National Nosocomial Infections Surveillance (NNIS) System

DOI: 10.2307/30140945

关键词: PseudomonadaceaeAntibacterial agentMicrococcaceaeStaphylococcus aureusMicrobiologyCiprofloxacinPseudomonas aeruginosaMedicineDrug resistanceAntibiotics

摘要: Objective We attempted to determine if an increase in resistance ciprofloxacin occurred among nosocomial pathogens, especially Pseudomonas aeruginosa and Staphylococcus aureus. Methods examined 1989-1992 susceptibility results from 8,517 P 9,021 S aureus isolates associated with infections reported the National Nosocomial Infections Surveillance System. Results For aureus, 27.1% of were resistant ciprofloxacin; methicillin-resistant isolates, 80% also ciprofloxacin. A logistic regression model found that was more common isolated urinary respiratory tracts than other sites isolation, methicillin resistant. After controlling for these factors, showed a 123% odds 1989-1990 1991-1992. aeruginosa, 4.7% Resistance varied by site infection rose most dramatically tract 2.0% 5.3% Conclusion is frequent increasing rapidly selected isolates.

参考文章(37)
Michael F. Parry, Kevin B. Panzer, Marie E. Yukna, Quinolone resistance: Susceptibility data from a 300-bed community hospital The American Journal of Medicine. ,vol. 87, ,(1989) , 10.1016/0002-9343(89)90012-0
Les Baillie, Ciproflaxacin-resistant pseudomonas-aeruginosa strain Medical laboratory sciences. ,vol. 46, pp. 92- ,(1989)
S Schaefler, Methicillin-resistant strains of Staphylococcus aureus resistant to quinolones. Journal of Clinical Microbiology. ,vol. 27, pp. 335- 336 ,(1989) , 10.1128/JCM.27.2.335-336.1989
Helio S Sader, Antonio C Pignatari, Richard J Hollis, Ivani Leme, Ronald N Jones, None, Oxacillin- and quinolone-resistant Staphylococcus aureus in Sao Paulo, Brazil: a multicenter molecular epidemiology study. Infection Control and Hospital Epidemiology. ,vol. 14, pp. 260- 264 ,(1993) , 10.2307/30148363
P. Maple, J. Hamilton-Miller, W. Brumfitt, Ciprofloxacin resistance in methicillin- and gentamicin-resistant Staphylococcus aureus. European Journal of Clinical Microbiology & Infectious Diseases. ,vol. 8, pp. 622- 624 ,(1989) , 10.1007/BF01968141
H L Muytjens, J van der Ros-van de Repe, G van Veldhuizen, Comparative activities of ciprofloxacin (Bay o 9867), norfloxacin, pipemidic acid, and nalidixic acid. Antimicrobial Agents and Chemotherapy. ,vol. 24, pp. 302- 304 ,(1983) , 10.1128/AAC.24.2.302
Max Michael, Trying to see the doctor: an American nightmare. The American Journal of Medicine. ,vol. 87, pp. 125- 126 ,(1989) , 10.1016/S0002-9343(89)80685-0
R. C. George, L. C. Ball, P. B. Norbury, Susceptibility to ciprofloxacin of nosocomial Gram-negative bacteria and staphylococci isolated in the UK Journal of Antimicrobial Chemotherapy. ,vol. 26, pp. 145- 156 ,(1990) , 10.1093/JAC/26.SUPPL_F.145